Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CTHR Charles and Colvard Ltd

1,235

-0,045 (-3,52%)

29 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Charles and Colvard (NASDAQ:CTHR)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Charles and Colvard Charts.

Charles and Colvard (NASDAQ:CTHR)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Charles and Colvard Charts.

News Charles and Colvard Ltd

Form 8-K - Current report
Mittwoch 27 November 2024 (2 Tage vor) • Edgar (US Regulatory)

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
Mittwoch 27 November 2024 (2 Tage vor) • PR Newswire (US)

Form 8-K - Current report
Freitag 15 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Freitag 15 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
Donnerstag 14 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
Donnerstag 24 Oktober 2024 (1 Monat vor) • PR Newswire (US)

Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders
Montag 7 Oktober 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 1 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Dienstag 1 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Dienstag 1 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Montag 16 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Charles and Colvard Ltd News-Artikel

Health Care Select Sector

Euro vs US Dollar

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen